Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

A sleep apnea headache usually happens upon waking and involves pain described as a pressing sensation on both sides of the head. It’s believed that they occur due to sleep apnea. Read on for more ...

Teddy Roosevelt, Long Island’s only U.S. president, inspired the “teddy bear” doll that little tykes once snuggled with for a good night’s sleep. At bedtime, though, you wouldn't want to be near the ...

Here’s what it looks like — and what experts say you can do to avoid it.